Predictors of Adherence to Repeat Fecal Occult Blood Test in a Population-based Colorectal Cancer Screening Program

Overview

Journal Br J Cancer

Specialty Oncology

Date 2014 Oct 15

PMID 25314056

Citations 19

Authors

C Pornet

B Denis

P Perrin

I Gendre

G Launoy

Affiliations

Soon will be listed here.

Abstract

Background: Socio-economic, environmental factors and general practitioner (GP) involvement may influence adherence to repeat faecal occult blood testing (FOBT) of organised colorectal cancer (CRC) screening. The aim of the study was to identify predictors of adherence to repeat testing.

Methods: The populationcomprised people eligible for the third round of a CRC screening programme in a French district (n=118,905). Multilevel logistic regression analysis was performed to identify individual and area-level characteristics associated with 'compliant participants' participating in the all three rounds vs 'occasional participants' participating in one or two rounds.

Results: Compared to 'occasional participants', 'compliant participants' were more likely to participate after receiving a FOBT kit from their GP (odds ratio (OR), 10.7; 95% CI, 10.01-11.5) vs FOBT received at home, and were less likely to live in socio-economically deprived areas (OR, 0.75; 0.70-0.80) and urban areas (OR, 0.94; 0.88-1.00).

Conclusions: As for a screening round participation, strategies aimed at improving the participation to a screening programme should target GPs and people living in socially deprived areas.

Citing Articles

Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center clinics: A stepped-wedge, multilevel intervention trial.

Montoya S, Olaore P, Bastardo-Acosta J, Abdulla R, Schell M, Hidalgo A Res Sq. 2024; .

PMID: 39070625 PMC: 11275978. DOI: 10.21203/rs.3.rs-4558718/v1.

Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD).

Guittet L, Quipourt V, Aparicio T, Carola E, Seitz J, Paillaud E BMC Cancer. 2023; 23(1):17.

PMID: 36604640 PMC: 9817257. DOI: 10.1186/s12885-022-10418-5.

Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.

Walker M, Meggetto O, Gao J, Espino-Hernandez G, Jembere N, Bravo C Prev Med. 2021; 151:106586.

PMID: 34217413 PMC: 9755643. DOI: 10.1016/j.ypmed.2021.106586.

Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals.

Benamouzig R, Barre S, Saurin J, Leleu H, Vimont A, Taleb S Therap Adv Gastroenterol. 2021; 14:17562848211002359.

PMID: 33953799 PMC: 8042553. DOI: 10.1177/17562848211002359.

Solis-Ibinagagoitia M, Unanue-Arza S, Diaz-Seoane M, Martinez-Indart L, Lebena-Maluf A, Idigoras I Front Public Health. 2020; 8:604385.

PMID: 33363095 PMC: 7760939. DOI: 10.3389/fpubh.2020.604385.

References

Gellad Z, Stechuchak K, Fisher D, Olsen M, McDuffie J, Ostbye T . Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol. 2011; 106(6):1125-34. DOI: 10.1038/ajg.2011.11. View

Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L . Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation. Am J Gastroenterol. 2009; 105(1):188-98. DOI: 10.1038/ajg.2009.583. View

Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G . Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Health. 2009; 64(4):318-24. DOI: 10.1136/jech.2008.081117. View

Weber M, Banks E, Ward R, Sitas F . Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort. J Med Screen. 2008; 15(3):137-42. DOI: 10.1258/jms.2008.008050. View

Liss D, Petit-Homme A, Feinglass J, Buchanan D, Baker D . Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health. 2013; 38(5):829-33. DOI: 10.1007/s10900-013-9685-x. View

Ferrat E, Le Breton J, Veerabudun K, Bercier S, Brixi Z, Khoshnood B . Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer. 2013; 109(6):1437-44. PMC: 3776987. DOI: 10.1038/bjc.2013.476. View

Federici A, Rossi P, Bartolozzi F, Farchi S, Borgia P, Guastcchi G . The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy). Cancer Causes Control. 2006; 17(1):45-52. DOI: 10.1007/s10552-005-0380-9. View

Wee C, McCarthy E, Phillips R . Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005; 41(1):23-9. DOI: 10.1016/j.ypmed.2004.11.004. View

Launoy G, Duffy S, Prevost T, Bouvier V . [Detection of cancer, sensitivity of the test and sensitivity of the screening program]. Rev Epidemiol Sante Publique. 1998; 46(5):420-6. View

10.

Frederiksen B, Jorgensen T, Brasso K, Holten I, Osler M . Socioeconomic position and participation in colorectal cancer screening. Br J Cancer. 2010; 103(10):1496-501. PMC: 2990593. DOI: 10.1038/sj.bjc.6605962. View

11.

Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L . Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health. 2012; 66(11):982-9. PMC: 3465837. DOI: 10.1136/jech-2011-200311. View

12.

Fenton J, Elmore J, Buist D, Reid R, Tancredi D, Baldwin L . Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med. 2010; 8(5):397-401. PMC: 2939414. DOI: 10.1370/afm.1133. View

13.

Dailey A, Brumback B, Livingston M, Jones B, Curbow B, Xu X . Area-level socioeconomic position and repeat mammography screening use: results from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2011; 20(11):2331-44. DOI: 10.1158/1055-9965.EPI-11-0528. View

14.

Leuraud K, Jezewski-Serra D, Viguier J, Salines E . Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer Epidemiol. 2013; 37(6):959-67. DOI: 10.1016/j.canep.2013.07.008. View

15.

Breton J, Journy N, Attali C, Le Corvoisier P, Brixi Z, Bastuji-Garin S . Improving participation in colorectal cancer screening: targets for action. Prev Med. 2012; 55(5):488-92. DOI: 10.1016/j.ypmed.2012.08.004. View

16.

von Wagner C, Good A, Wright D, Rachet B, Obichere A, Bloom S . Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer. 2009; 101 Suppl 2:S60-3. PMC: 2790701. DOI: 10.1038/sj.bjc.6605392. View